CRISPR Therapeutics AG
CRISPR Therapeutics AG (CRSP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
crsp · stock forecast · 38 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 38 Wall Street analysts in the past 3 months
Buy
38 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$82.00
Consensus
$64.60
+25.6% upside
Low
$33.00
Median: $76 · Last Close: $51.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$64.60
25.6% upside
High Target
$82
59.4%
Low Target
$33
-35.9%
Current Price
$51.45
as of today
Based on analyst price targets, the CRSP stock price prediction for the next 12 months ranges from $33 to $82. The consensus CRSP price forecast of $64.60 implies 25.6% upside from the current price of $51.45.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $52.03 | ↑ 1.12% |
1-day model range: $51.67–$52.39. Peak: $52.39 (+1.12%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $36 | -30.9% |
| 2028 | $29 | -43.7% |
| 2029 | $26 | -49.9% |
| 2030 | $24 | -53.3% |
| 2031 | — | -55.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRSP · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Bernstein | Maintains | Market Perform→Market Perform |
| 2026-05-06 | Citigroup | Maintains | Buy→Buy |
| 2026-03-17 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-02-17 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-13 | TD Cowen | Maintains | Hold→Hold |
| 2026-02-13 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-02-13 | Needham | Maintains | Buy→Buy |
| 2026-01-30 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-23 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-23 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CRISPR Therapeutics AG (CRSP) stock. Of the recent 225 rating actions, 7 were upgrades and 9 were downgrades. 38 analysts currently cover CRSP.
Analyst Recommendation Trends
CRSP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$40M
↓ 93.2% YoY
Revenue Next Year
$138M
↑ 247.8% YoY
EPS This Year
$-4.87
EPS Next Year
$-3.62
↓ 25.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRSP EPS of $-4.87 for the current fiscal year, based on estimates from 17 analysts. The CRSP revenue forecast is $40M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CRSP stock forecast is supported by two independent data sources: analyst consensus ratings from 38 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CRSP price target is $64.60 (+25.6% upside), with an analyst consensus of Buy.
The CRSP short-term stock prediction for tomorrow is $52.03 (+1.12%). The CRSP stock price prediction for 2027 estimates an average of $36. The CRSP stock prediction for 2030 projects a range of $22–$26.
CRISPR Therapeutics AG trades on NASDAQ under the ticker CRSP. The CRSP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 58% of covering analysts.
Frequently asked questions
CRSP forecast · 8 questionsAccording to 38 Wall Street analysts, the average 12-month CRSP price target is $64.60, with a high forecast of $82.00 and a low of $33.00. The median price target is shown in the chart above when available. This implies +25.6% potential upside from the current price of $51.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.